Search
Search Results
##search.searchResults.foundPlural##
-
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2569PDF: 1599HTML: 2346Table1: 187 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1536PDF: 596HTML: 180 -
BONE MARROW ABONRMALITIES IN HIV INFECTION
1844PDF: 1126HTML: 1750 -
Monocyte HLA-Dr Expression to Monitor Immune Response and Potential Infection Risks Following Vaso-Occlusive Crises in Patients with Sickle Cell Anemia Monocyte HLA-DR expression in SCA patients
670PDF: 519HTML: 202 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
3840PDF: 1466HTML: 8502 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
1904PDF: 1149HTML: 262 -
-
Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY GENE THERAPY FOR HEMOPHILIA
2010PDF: 1846HTML: 338 -
RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM
1163PDF: 1051HTML: 184 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4025PDF: 1915HTML: 5211Table 1: 181 -
BACK TO THE “GOLD STANDARD”: HOW PRECISE IS HEMATOCRIT DETECTION TODAY? Novel ImageJ-based approach for the precise hematocrit measurement
1980PDF: 814HTML: 459 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3557PDF: 870HTML: 6702 -
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3271PDF: 1944HTML: 7466 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7382PDF: 2403HTML: 1715Table 1.: 201Table 2.: 213Table 3.: 194Table 4.: 194 -
STUDY OF SERUM HAPTOGLOBIN LEVEL AND ITS RELATION TO ERYTHROPOIETIC ACTIVITY IN BETA THALASSEMIA CHILDREN .
2154PDF: 1160HTML: 2576Study of serum haptoglobin level in thalassemia: 339Figures: 172 -
-
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4653PDF: 2802HTML: 2268 -
SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology
1024PDF: 957HTML: 317 -
COAGULOPATHY IN BETA-THALASSEMIA: CURRENT UNDERSTANDING AND FUTURE PERSPECTIVES
1070PDF: 482HTML: 8151 -
DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA
2871PDF: 1575HTML: 224 -
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2361PDF: 1571HTML: 607 -
SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.
3216PDF: 1065HTML: 425 -
DETECTION OF ANTINUCLEAR ANTIBODIES TARGETING INTRACELLULAR SIGNAL TRANSDUCTION, METABOLISM, APOPTOTIC PROCESSES AND CELL DEATH IN CRITICAL COVID-19 PATIENTS
1276PDF: 940HTML: 275Suppl. Figure: 180Suppl. Tables: 201 -
ENDOTHELIAL BIOMARKERS IN PATIENTS RECOVERED FROM COVID-19 ONE YEAR AFTER HOSPITAL DISCHARGE: A CROSS-SECTIONAL STUDY Endothelial biomarkers in COVID-19 recoverers one year after hospital discharge.
1240PDF: 715HTML: 310







